226 related articles for article (PubMed ID: 20050840)
1. Safety of administration of human butyrylcholinesterase and its conjugates with soman or VX in rats.
Genovese RF; Sun W; Johnson CC; Ditargiani RC; Doctor BP; Saxena A
Basic Clin Pharmacol Toxicol; 2010 May; 106(5):428-34. PubMed ID: 20050840
[TBL] [Abstract][Full Text] [Related]
2. Conjugates of human serum butyrylcholinesterase and nerve agents are behaviorally safe in rhesus macaques.
Saxena A; Myers TM; Sipos ML
Chem Biol Interact; 2021 Aug; 344():109499. PubMed ID: 33961835
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX.
Saxena A; Sun W; Fedorko JM; Koplovitz I; Doctor BP
Biochem Pharmacol; 2011 Jan; 81(1):164-9. PubMed ID: 20846507
[TBL] [Abstract][Full Text] [Related]
4. Effect of polyethylene glycol conjugation on the circulatory stability of plasma-derived human butyrylcholinesterase in mice.
Sun W; Luo C; Tipparaju P; Doctor BP; Saxena A
Chem Biol Interact; 2013 Mar; 203(1):172-6. PubMed ID: 23220586
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-transduced human butyrylcholinesterase in mouse blood functions as a bioscavenger of chemical warfare nerve agents.
Chilukuri N; Duysen EG; Parikh K; diTargiani R; Doctor BP; Lockridge O; Saxena A
Mol Pharmacol; 2009 Sep; 76(3):612-7. PubMed ID: 19542320
[TBL] [Abstract][Full Text] [Related]
6. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase.
Raveh L; Grauer E; Grunwald J; Cohen E; Ashani Y
Toxicol Appl Pharmacol; 1997 Jul; 145(1):43-53. PubMed ID: 9221822
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of human butyrylcholinesterase pretreatment followed by acute soman challenge in cynomolgus monkeys.
Sun W; Doctor BP; Lenz DE; Saxena A
Chem Biol Interact; 2008 Sep; 175(1-3):428-30. PubMed ID: 18674756
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous quantification of soman and VX adducts to butyrylcholinesterase, their aged methylphosphonic acid adduct and butyrylcholinesterase in plasma using an off-column procainamide-gel separation method combined with UHPLC-MS/MS.
Liu CC; Huang GL; Xi HL; Liu SL; Liu JQ; Yu HL; Zhou SK; Liang LH; Yuan L
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1036-1037():57-65. PubMed ID: 27718463
[TBL] [Abstract][Full Text] [Related]
9. Assessment of low level whole-body soman vapor exposure in rats.
Genovese RF; Benton BJ; Johnson CC; Jakubowski EM
Neurotoxicol Teratol; 2009; 31(2):110-8. PubMed ID: 19026741
[TBL] [Abstract][Full Text] [Related]
10. Butyrylcholinesterase in guinea pig lung lavage: a novel biomarker to assess lung injury following inhalation exposure to nerve agent VX.
Graham JR; Wright BS; Rezk PE; Gordon RK; Sciuto AM; Nambiar MP
Inhal Toxicol; 2006 Jun; 18(7):493-500. PubMed ID: 16603480
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment with human serum butyrylcholinesterase alone prevents cardiac abnormalities, seizures, and death in Göttingen minipigs exposed to sarin vapor.
Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
Biochem Pharmacol; 2011 Dec; 82(12):1984-93. PubMed ID: 21968035
[TBL] [Abstract][Full Text] [Related]
12. Correlation between butyrylcholinesterase variants and sensitivity to soman toxicity.
Dimov D; Kanev K; Dimova I
Acta Biochim Pol; 2012; 59(2):313-6. PubMed ID: 22696303
[TBL] [Abstract][Full Text] [Related]
13. Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic model.
Ashani Y; Pistinner S
Toxicol Sci; 2004 Feb; 77(2):358-67. PubMed ID: 14600276
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous Time-concentration Analysis of Soman and VX Adducts to Butyrylcholinesterase and Albumin by LC-MS-MS.
Lee JY; Kim C; Lee YH
J Anal Toxicol; 2018 Jun; 42(5):293-299. PubMed ID: 29618078
[TBL] [Abstract][Full Text] [Related]
15. Gene-delivered butyrylcholinesterase is prophylactic against the toxicity of chemical warfare nerve agents and organophosphorus compounds.
Parikh K; Duysen EG; Snow B; Jensen NS; Manne V; Lockridge O; Chilukuri N
J Pharmacol Exp Ther; 2011 Apr; 337(1):92-101. PubMed ID: 21205915
[TBL] [Abstract][Full Text] [Related]
16. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization.
Raveh L; Grunwald J; Marcus D; Papier Y; Cohen E; Ashani Y
Biochem Pharmacol; 1993 Jun; 45(12):2465-74. PubMed ID: 8328984
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of human serum butyrylcholinesterase against sarin vapor.
Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
Chem Biol Interact; 2008 Sep; 175(1-3):267-72. PubMed ID: 18597747
[TBL] [Abstract][Full Text] [Related]
18. Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality.
Duysen EG; Li B; Xie W; Schopfer LM; Anderson RS; Broomfield CA; Lockridge O
J Pharmacol Exp Ther; 2001 Nov; 299(2):528-35. PubMed ID: 11602663
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis with human serum butyrylcholinesterase protects Göttingen minipigs exposed to a lethal high-dose of sarin vapor.
Saxena A; Hastings NB; Sun W; Dabisch PA; Hulet SW; Jakubowski EM; Mioduszewski RJ; Doctor BP
Chem Biol Interact; 2015 Aug; 238():161-9. PubMed ID: 26145887
[TBL] [Abstract][Full Text] [Related]
20. Chemical synthesis of two series of nerve agent model compounds and their stereoselective interaction with human acetylcholinesterase and human butyrylcholinesterase.
Barakat NH; Zheng X; Gilley CB; MacDonald M; Okolotowicz K; Cashman JR; Vyas S; Beck JM; Hadad CM; Zhang J
Chem Res Toxicol; 2009 Oct; 22(10):1669-79. PubMed ID: 19715346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
